Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care.

Martin A, Van Hoof T, Stubbe D, Sherwin T, Scahill L.

Psychiatr Serv. 2003 Jan;54(1):72-7.

PMID:
12509670
2.

Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.

Radigan M, Lannon P, Roohan P, Gesten F.

J Child Adolesc Psychopharmacol. 2005 Feb;15(1):44-56.

PMID:
15741785
3.

Psychotropic medication patterns among youth in juvenile justice.

Lyons CL, Wasserman GA, Olfson M, McReynolds LS, Musabegovic H, Keating JM.

Adm Policy Ment Health. 2013 Mar;40(2):58-68. doi: 10.1007/s10488-011-0378-4.

PMID:
22001969
4.

Trends in psychotropic polypharmacy among youths enrolled in Ohio Medicaid, 2002-2008.

Fontanella CA, Warner LA, Phillips GS, Bridge JA, Campo JV.

Psychiatr Serv. 2014 Nov 1;65(11):1332-40. doi: 10.1176/appi.ps.201300410. Epub 2014 Oct 31.

5.

Growth in the concurrent use of antipsychotics with other psychotropic medications in Medicaid-enrolled children.

Kreider AR, Matone M, Bellonci C, dosReis S, Feudtner C, Huang YS, Localio R, Rubin DM.

J Am Acad Child Adolesc Psychiatry. 2014 Sep;53(9):960-970.e2. doi: 10.1016/j.jaac.2014.05.010. Epub 2014 Jun 19.

PMID:
25151419
6.

Multiple psychotropic medication use for youths: a two-state comparison.

dosReis S, Zito JM, Safer DJ, Gardner JF, Puccia KB, Owens PL.

J Child Adolesc Psychopharmacol. 2005 Feb;15(1):68-77.

PMID:
15741788
7.

Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.

Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ.

Clin Ther. 2007 Jan;29(1):183-95.

PMID:
17379060
8.

Trends in the prescribing of psychotropic medications to preschoolers.

Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F.

JAMA. 2000 Feb 23;283(8):1025-30.

PMID:
10697062
9.

The definition and prevalence of pediatric psychotropic polypharmacy.

Chen H, Patel A, Sherer J, Aparasu R.

Psychiatr Serv. 2011 Dec;62(12):1450-5. doi: 10.1176/appi.ps.000642011.

PMID:
22193792
10.

National trends in psychotropic medication polypharmacy in office-based psychiatry.

Mojtabai R, Olfson M.

Arch Gen Psychiatry. 2010 Jan;67(1):26-36. doi: 10.1001/archgenpsychiatry.2009.175.

PMID:
20048220
11.

Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.

Edelsohn GA, Schuster JM, Castelnovo K, Terhorst L, Parthasarathy M.

Psychiatr Serv. 2014 Feb 1;65(2):201-7. doi: 10.1176/appi.ps.201300029.

PMID:
24233105
12.

Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.

Zito JM, Safer DJ, Zuckerman IH, Gardner JF, Soeken K.

Psychiatr Serv. 2005 Feb;56(2):157-63.

PMID:
15703342
13.

Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.

Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky DE.

Pediatrics. 2008 Mar;121(3):e441-8. doi: 10.1542/peds.2007-0984.

14.

National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.

Comer JS, Olfson M, Mojtabai R.

J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):1001-10. doi: 10.1016/j.jaac.2010.07.007. Epub 2010 Sep 1.

15.

Psychotropic medication trends among children and adolescents with autism spectrum disorder in the Medicaid program.

Schubart JR, Camacho F, Leslie D.

Autism. 2014 Aug;18(6):631-7. doi: 10.1177/1362361313497537. Epub 2013 Oct 28.

PMID:
24165274
16.

Racial disparity in psychotropic medications prescribed for youths with Medicaid insurance in Maryland.

Zito JM, Safer DJ, dosReis S, Riddle MA.

J Am Acad Child Adolesc Psychiatry. 1998 Feb;37(2):179-84.

PMID:
9473914
17.

Psychotropic medication patterns among youth in foster care.

Zito JM, Safer DJ, Sai D, Gardner JF, Thomas D, Coombes P, Dubowski M, Mendez-Lewis M.

Pediatrics. 2008 Jan;121(1):e157-63. doi: 10.1542/peds.2007-0212.

PMID:
18166534
18.

Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.

Khanna R, Jariwala K, West-Strum D.

J Intellect Disabil Res. 2013 Feb;57(2):161-71. doi: 10.1111/j.1365-2788.2012.01563.x. Epub 2012 Apr 4.

PMID:
22471524
19.

Second-generation antipsychotic use among stimulant-using children, by organization of medicaid mental health.

Saloner B, Matone M, Kreider AR, Budeir MS, Miller D, Huang YS, Raghavan R, French B, Rubin D.

Psychiatr Serv. 2014 Dec 1;65(12):1458-64. doi: 10.1176/appi.ps.201300574. Epub 2014 Nov 17.

20.

Methylphenidate patterns among Medicaid youths.

Zito JM, Safer DJ, dosReis S, Magder LS, Riddle MA.

Psychopharmacol Bull. 1997;33(1):143-7.

PMID:
9133766
Items per page

Supplemental Content

Write to the Help Desk